EKF Diagnostics Holdings plc Overview
Pro stress-test →EKF Diagnostics is engaged in development, manufacture and supply of in-vitro diagnostic (IVD) products, deriving revenue from the manufacture and sale of medical diagnostic equipment and reagents. The company develops point-of-care diagnostic devices and tests, providing quick, accurate results for healthcare professionals to make rapid decisions at or near the patient's location.
Strategic Profile
Pro stress-test →The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. Its businesses include Point-of-Care, Central Laboratory, Life Sciences, and Contract Manufacturing, serving areas such as diabetes, hematology, infectious diseases, clinical chemistry, and sports medicine.
Competitive Landscape
Pro stress-test →EKF operates in the fragmented in-vitro diagnostics market competing against larger diversified medical device companies (Roche, Abbott, Siemens) in point-of-care diagnostics and against specialized regional players in reagents and analyzers. The company's competitive advantage lies in niche point-of-care and life sciences markets rather than high-volume clinical chemistry.
Industry Context
EKF Diagnostics Holdings plc operates in In-Vitro Diagnostics (IVD) / Medical Devices.
Key facts
Headquarters: Penarth, UK · Revenue: £56.04M · Market cap: £138.61M